BioCentury
ARTICLE | Top Story

Fosun off in Hong Kong debut

October 31, 2012 12:35 AM UTC

Shanghai Fosun Pharmaceuticals Group Co. Ltd. (Shanghai:600196; HKSE:02196) was off HK$0.96 to HK$10.84 in its first day of trading on Tuesday on the Hong Kong Stock Exchange. Last week, the company raised HK$4 billion ($511.6 million) through the sale of 336.1 million shares at HK$11.80. Fosun Pharmaceuticals' pipeline consists of pharmaceutical and traditional Chinese medicine products for metabolic, CNS and infectious diseases, as well as cancer (see BioCentury, Oct. 29). ...